Quarterly report · Q1
3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥43.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥40.5bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥999m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥104.0bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥98.1bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥54.7bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥49.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥44.5bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥27.22 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.18 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥102m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥876m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥39.6bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥39.5bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥86m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥327m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥43.5bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥43.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥102m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥2.7bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥77m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥830m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.2bn |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥17m |
| jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.1bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥3.5bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.4bn |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥60m |
| jpcrp040300-q1r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥349m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥40.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥40.5bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥77m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 351
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 中 淳 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)渡 邊 崇 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 40550000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 43403000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 170036000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1760000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1940000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 10098000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1001000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1010000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5656000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1002000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1009000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5657000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 44450000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 49302000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 48856000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 98114000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 104039000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 101905000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 27.18 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 27.22 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 152.96 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.453 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.473 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.479 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1200200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 37672000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 376720 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 30585 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 38902785 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 376720 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0308 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |